A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: Efficient maturation of DCs by co-culture with LAK cells in vitro

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 147-152

  Yano, Yutaro ^a   Ueda, Yuji ^a   Itoh, Tsuyohi ^a   Fuji, Nobuaki ^a   Okugawa, Kaori ^a   Naito, Kei ^a   Imura, Kenichiro ^a   Kohara, Junji ^a   Hayashi, Takashi ^b   Nakane, Kazuki ^c   Matsuura, Yuko ^c   Kawai, Keiichi ^c   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Center for Cerebrovascular Disease   (Japan)

^c Inariyama Hospital   (Japan)

Author keywords

Cancer immunotherapy; CD40 CD40 ligand interaction; Cytokine; Dendritic cell; Lymphokine activated killer cell

Indexed keywords

CD40 ANTIGEN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL TRANSPLANTATION; COCULTURE; CYTOLOGY; DENDRITIC CELL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOKINE ACTIVATED KILLER CELL; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM;

ADULT; AGED; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY; KILLER CELLS, LYMPHOKINE-ACTIVATED; MALE; MIDDLE AGED; NEOPLASMS;

EID: 33750729915     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.147     Document Type: Article

References (23)

1. Banchereau J and Palucka AK: Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296-306, 2005. (Pubitemid 40516155)
2. Davis ID, Jefford M, Parente P and Cebon J: Rational approaches to human cancer immunotherapy. J Leuk Biol 73: 3-29, 2003. (Pubitemid 36125672)
3. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C and Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238, 2001. (Pubitemid 32524454)
4. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E and Schuler G: Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190: 1669-1678, 1999. (Pubitemid 30002348)
5. Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe SM, Dunbar PR, Cerundolo V, Nixon DF and Bhardwaj N: Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 104: 173-180, 2005.
6. Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P, Bender A, Feuerstein B, Fritsch PO, Romani N and Schuler G: Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med 195: 1279-1288, 2002. (Pubitemid 34564330)
7. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J and Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142, 1997. (Pubitemid 28018007)
8. Sato T, Tera M, Yasuda R, Watanabe R, Berd D, Mastrangelo MJ and Hasumi K: Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy. Cancer Immunol Immunother 5: 53-61, 2004. (Pubitemid 38161181)
9. Caux C, Massacrier C, Vanbervliet B, Dubois B, van Kooten C, Durand I and Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180: 1263-1272, 1994. (Pubitemid 24289600)
10. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A and Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184: 747-752, 1996. (Pubitemid 26324129)
11. McLellan AD, Sorg RV, Williams LA and Hart DN: Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur J Immunol 26: 1204-1210, 1996.
12. Grimm EA, Mazumder A, Zhang HZ and Rosenberg SA: Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823-1841, 1982. (Pubitemid 12074218)
13. Ohkawa T, Seki S, Dobashi H, Koike Y, Habu Y, Ami K, Hiraide H and Sekine I: Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology 103: 281-290, 2001. (Pubitemid 32626177)
14. Sato M, Iwakabe K, Ohta A, Sekimoto M, Nakui M, Koda T, Kimura S and Nishimura T: Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes. Int Immunol 12: 335-342, 2000. (Pubitemid 30142705)
15. Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM and Mailliard RB: Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol 42: 535-539, 2005. (Pubitemid 39655965)
16. Sato M, Chamoto K and Nishimura T: A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells. Int Immunol 15: 837-843, 2003. (Pubitemid 36827072)
17. Biron CA: Activation and function of natural killer cell responses during via infections. Curr Opin Immunol 9: 24-34, 1997.
18. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998. (Pubitemid 28155090)
19. Biron CA and Brossay L: NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 13: 458-464, 2001. (Pubitemid 32728479)
20. Piccioli D, Sbrana S, Melandri E and Valiante NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195: 335-341, 2002. (Pubitemid 34461491)
21. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM and Munz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195: 343-351, 2002. (Pubitemid 34461492)
22. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G and Trinchieri G: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195: 327-333, 2002. (Pubitemid 34461490)
23. Oner O, Ravindranath Y and Savasan S: Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells. J Immunother 28: 44-52, 2005. (Pubitemid 40075937)